Clorox amends bylaws to add cure process for shareholder nomination deficiencies

CLOROX CO /DE/

Board adopted amended bylaws effective May 19, 2025.
New cure process allows shareholders to fix deficiencies in director nomination notices.
Company will notify shareholders of deficiencies and provide a specified cure period.
Amendment applies to nomination notices received within the bylaws' time window.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.95

CLOROX CO /DE/: Amended and restated bylaws to implement a cure process for deficiencies in director nomination notices submitted by shareholders. The Company will notify shareholders of deficiencies, allowing them an opportunity to cure within a specified time period (effective 2025-05-19).

Change: bylaw amendment
Effective: 2025-05-19

Exact text from the filing

The Board of Directors of The Clorox Company (the “Company”) amended and restated the Company’s bylaws (the “Bylaws”), effective May 19, 2025. The amendments implement a cure process for certain deficiencies in director nomination notices submitted by shareholders. For nomination notices received by the Company within the time period specified in the Bylaws, the Company will notify shareholders of deficiencies in the notice and there will be an opportunity to cure such deficiencies within the time period specified.

View on SEC.gov

89 governance changes filed in the last 30 days. Browse all governance changes →

CLOROX CO /DE/ filing history →

Source: SEC EDGAR

accession 0001206774-25-000377

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.